Obesity drugmaker Rivus is working with banks to complete a US public listing that could happen before the end of the year.
Our daily email brings you smart and engaging news and analysis on the biggest stories in business and finance. For free.
It’s not quite Christmas yet, but Amazon is putting cash in the stocking of its favorite AI startup, Anthropic.
In the coming decades, the Silent Generation and aging Baby Boomers are projected to hand down trillions in wealth. So who will benefit?
Novartis is banking on the startup’s promising treatment candidates for neuromuscular diseases, many of which are genetic in nature.